BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17331591)

  • 1. Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine.
    Melkebeek V; Verdonck F; Goddeeris BM; Cox E
    Vet Immunol Immunopathol; 2007 Apr; 116(3-4):199-214. PubMed ID: 17331591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
    Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
    J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized FaeG expression and a thermolabile enterotoxin DNA adjuvant enhance priming of an intestinal immune response by an FaeG DNA vaccine in pigs.
    Melkebeek V; Sonck E; Verdonck F; Goddeeris BM; Cox E
    Clin Vaccine Immunol; 2007 Jan; 14(1):28-35. PubMed ID: 17108289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X; Liu M; Casey TA; Zhang W
    Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of immune responses in pigs following oral administration of purified F4 fimbriae.
    Van den Broeck W; Cox E; Goddeeris BM
    Vaccine; 1999 Apr; 17(15-16):2020-9. PubMed ID: 10217602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera toxin improves the F4(K88)-specific immune response following oral immunization of pigs with recombinant FaeG.
    Verdonck F; Snoeck V; Goddeeris BM; Cox E
    Vet Immunol Immunopathol; 2005 Jan; 103(1-2):21-9. PubMed ID: 15626459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with F4 fimbriae and CpG formulated with carboxymethyl starch enhances F4-specific mucosal immune response and modulates Th1 and Th2 cytokines in weaned pigs.
    Delisle B; Calinescu C; Mateescu MA; Fairbrother JM; Nadeau É
    J Pharm Pharm Sci; 2012; 15(5):642-56. PubMed ID: 23331903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the Neutralizing Epitopes of Enterotoxigenic Escherichia coli K88 (F4) Fimbrial Adhesin and Major Subunit FaeG.
    Lu T; Moxley RA; Zhang W
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.
    Luo Q; Vickers TJ; Fleckenstein JM
    Clin Vaccine Immunol; 2016 Jul; 23(7):628-37. PubMed ID: 27226279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
    Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
    Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naked DNA when co-administered intranasally with heat-labile enterotoxin of Escherichia coli primes effectively for systemic B- and T-cell responses to the encoded antigen.
    Kanellos TS; Byarugaba DK; Russell PH; Howard CR; Partidos CD
    Immunol Lett; 2000 Nov; 74(3):215-20. PubMed ID: 11064104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.
    Moravec T; Schmidt MA; Herman EM; Woodford-Thomas T
    Vaccine; 2007 Feb; 25(9):1647-57. PubMed ID: 17188785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice.
    Maciel M; Smith M; Poole ST; Laird RM; Rollenhagen JE; Kaminski RW; Wenzel H; Bourgeois AL; Savarino SJ
    PLoS One; 2019; 14(11):e0224073. PubMed ID: 31682624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced faecal excretion of F4+-E coli by the intramuscular immunisation of suckling piglets by the addition of 1alpha,25-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides.
    Van der Stede Y; Cox E; Verdonck F; Vancaeneghem S; Goddeeris BM
    Vaccine; 2003 Feb; 21(9-10):1023-32. PubMed ID: 12547616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae.
    Van den Broeck W; Cox E; Goddeeris BM
    Infect Immun; 1999 Feb; 67(2):520-6. PubMed ID: 9916054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine.
    Jones FR; Hall ER; Tribble D; Savarino SJ; Cassels FJ; Porter C; Meza R; Nunez G; Espinoza N; Salazar M; Luckett R; Scott D
    Vaccine; 2006 May; 24(18):3786-92. PubMed ID: 16343702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.